202 related articles for article (PubMed ID: 32265226)
1. Induction of DNMT3B by PGE2 and IL6 at Distant Metastatic Sites Promotes Epigenetic Modification and Breast Cancer Colonization.
So JY; Skrypek N; Yang HH; Merchant AS; Nelson GW; Chen WD; Ishii H; Chen JM; Hu G; Achyut BR; Yoon EC; Han L; Huang C; Cam MC; Zhao K; Lee MP; Yang L
Cancer Res; 2020 Jun; 80(12):2612-2627. PubMed ID: 32265226
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E
Wong CC; Kang W; Xu J; Qian Y; Luk STY; Chen H; Li W; Zhao L; Zhang X; Chiu PW; Ng EK; Yu J
Theranostics; 2019; 9(21):6256-6268. PubMed ID: 31534549
[No Abstract] [Full Text] [Related]
3. COX-2 induces oncogenic micro RNA miR655 in human breast cancer.
Majumder M; Dunn L; Liu L; Hasan A; Vincent K; Brackstone M; Hess D; Lala PK
Sci Rep; 2018 Jan; 8(1):327. PubMed ID: 29321644
[TBL] [Abstract][Full Text] [Related]
4. DNA Methyltransferase 3B-Mediated Intratumoral Heterogeneity and Therapeutic Targeting in Breast Cancer Recurrence and Metastasis.
So JY; Yang HH; Park WY; Skrypek N; Ishii H; Chen JM; Lee MP; Yang L
Mol Cancer Res; 2022 Nov; 20(11):1674-1685. PubMed ID: 35857355
[TBL] [Abstract][Full Text] [Related]
5. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
[TBL] [Abstract][Full Text] [Related]
6. Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.
Qin G; Xu F; Qin T; Zheng Q; Shi D; Xia W; Tian Y; Tang Y; Wang J; Xiao X; Deng W; Wang S
Oncotarget; 2015 Dec; 6(39):41794-808. PubMed ID: 26540629
[TBL] [Abstract][Full Text] [Related]
7. Hiltonol Cocktail Kills Lung Cancer Cells by Activating Cancer-Suppressors, PKR/OAS, and Restraining the Tumor Microenvironment.
Chang SC; Zhang BX; Su EC; Wu WC; Hsieh TH; Salazar AM; Lin YK; Ding JL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562773
[TBL] [Abstract][Full Text] [Related]
8. Combinatorial treatment with polyI:C and anti-IL6 enhances apoptosis and suppresses metastasis of lung cancer cells.
Lau WH; Zhu XG; Ho SWT; Chang SC; Ding JL
Oncotarget; 2017 May; 8(20):32884-32904. PubMed ID: 28427199
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the S1P
Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
[TBL] [Abstract][Full Text] [Related]
10. Single-cell RNA sequencing of lung adenocarcinoma reveals heterogeneity of immune response-related genes.
Ma KY; Schonnesen AA; Brock A; Van Den Berg C; Eckhardt SG; Liu Z; Jiang N
JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30821712
[TBL] [Abstract][Full Text] [Related]
11. COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis.
Majumder M; Xin X; Liu L; Tutunea-Fatan E; Rodriguez-Torres M; Vincent K; Postovit LM; Hess D; Lala PK
Stem Cells; 2016 Sep; 34(9):2290-305. PubMed ID: 27301070
[TBL] [Abstract][Full Text] [Related]
12. Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling.
Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Opavsky R
EBioMedicine; 2021 Jan; 63():103191. PubMed ID: 33418509
[TBL] [Abstract][Full Text] [Related]
13. Separation of breast cancer and organ microenvironment transcriptomes in metastases.
Alzubi MA; Turner TH; Olex AL; Sohal SS; Tobin NP; Recio SG; Bergh J; Hatschek T; Parker JS; Sartorius CA; Perou CM; Dozmorov MG; Harrell JC
Breast Cancer Res; 2019 Mar; 21(1):36. PubMed ID: 30841919
[TBL] [Abstract][Full Text] [Related]
14. Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patients.
Jahangiri R; Jamialahmadi K; Gharib M; Emami Razavi A; Mosaffa F
Gene; 2019 Feb; 685():24-31. PubMed ID: 30359738
[TBL] [Abstract][Full Text] [Related]
15. The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity.
Liu C; Zheng S; Jin R; Wang X; Wang F; Zang R; Xu H; Lu Z; Huang J; Lei Y; Mao S; Wang Y; Feng X; Sun N; Wang Y; He J
Cancer Lett; 2020 Feb; 470():95-105. PubMed ID: 31644929
[TBL] [Abstract][Full Text] [Related]
16. LincRNA-p21 knockdown reversed tumor-associated macrophages function by promoting MDM2 to antagonize* p53 activation and alleviate breast cancer development.
Zhou L; Tian Y; Guo F; Yu B; Li J; Xu H; Su Z
Cancer Immunol Immunother; 2020 May; 69(5):835-846. PubMed ID: 32062693
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Modification Is Regulated by the Interaction of Influenza A Virus Nonstructural Protein 1 with the
Liu S; Liu L; Xu G; Cao Z; Wang Q; Li S; Peng N; Yin J; Yu H; Li M; Xia Z; Zhou L; Lin Y; Wang X; Li Q; Zhu C; Yang X; Wang J; She Y; Lu M; Zhu Y
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651365
[TBL] [Abstract][Full Text] [Related]
18. Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment.
Tsukamoto H; Fujieda K; Miyashita A; Fukushima S; Ikeda T; Kubo Y; Senju S; Ihn H; Nishimura Y; Oshiumi H
Cancer Res; 2018 Sep; 78(17):5011-5022. PubMed ID: 29967259
[TBL] [Abstract][Full Text] [Related]
19. The progress and confusion of anti-PD1/PD-L1 immunotherapy for patients with advanced non-small cell lung cancer.
Zhang S; Bai X; Shan F
Int Immunopharmacol; 2020 Mar; 80():106247. PubMed ID: 32007710
[TBL] [Abstract][Full Text] [Related]
20. Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation.
Cadassou O; Raza MZ; Machon C; Gudefin L; Armanet C; Chettab K; Guitton J; Tozzi MG; Dumontet C; Cros-Perrial E; Jordheim LP
Cell Oncol (Dordr); 2021 Feb; 44(1):151-165. PubMed ID: 32970317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]